MRI is widely-regarded as the superior diagnostic imaging modality for monitoring and diagnosing women with a heightened genomic and phenomic risk for Breast Cancer.

We are applying proprietary IP and clinical excellence to identify, biopsy, and optimally treat early-stage Breast Cancer.​